Incidence of Mutations in the ALPL, GGPS1, and CYP1A1 Genes in Patients With Atypical Femoral Fractures
P Peris, E González Roca… - Journal of Bone and …, 2019 - academic.oup.com
Atypical femoral fractures (AFFs) are uncommon and often related to prolonged
bisphosphonate (BP) treatment. Isolated cases have been linked to mutations of tissue …
bisphosphonate (BP) treatment. Isolated cases have been linked to mutations of tissue …
Incidence of Mutations in the ALPL, GGPS1, and CYP1A1 Genes in Patients With Atypical Femoral Fractures.
P Peris, E González-Roca, SC Rodríguez-García… - JBMR Plus, 2018 - europepmc.org
Atypical femoral fractures (AFFs) are uncommon and often related to prolonged
bisphosphonate (BP) treatment. Isolated cases have been linked to mutations of tissue …
bisphosphonate (BP) treatment. Isolated cases have been linked to mutations of tissue …
Incidence of Mutations in the ALPL, GGPS1, and CYP1A1 Genes in Patients With Atypical Femoral Fractures
P Peris, E González‐Roca, SC Rodríguez‐García… - JBMR …, 2019 - search.proquest.com
Atypical femoral fractures (AFFs) are uncommon and often related to prolonged
bisphosphonate (BP) treatment. Isolated cases have been linked to mutations of tissue …
bisphosphonate (BP) treatment. Isolated cases have been linked to mutations of tissue …
Incidence of Mutations in the ALPL, GGPS1, and CYP1A1 Genes in Patients With Atypical Femoral Fractures
P Peris, E González‐Roca, SC Rodríguez‐García… - JBMR Plus, 2019 - Wiley Online Library
Atypical femoral fractures (AFFs) are uncommon and often related to prolonged
bisphosphonate (BP) treatment. Isolated cases have been linked to mutations of tissue …
bisphosphonate (BP) treatment. Isolated cases have been linked to mutations of tissue …
[HTML][HTML] Incidence of Mutations in the ALPL, GGPS1, and CYP1A1 Genes in Patients With Atypical Femoral Fractures
P Peris, E González‐Roca, SC Rodríguez‐García… - JBMR Plus, 2019 - ncbi.nlm.nih.gov
Atypical femoral fractures (AFFs) are uncommon and often related to prolonged
bisphosphonate (BP) treatment. Isolated cases have been linked to mutations of tissue …
bisphosphonate (BP) treatment. Isolated cases have been linked to mutations of tissue …
Incidence of Mutations in the ALPL, GGPS1, and CYP1A1 Genes in Patients With Atypical Femoral Fractures
P Peris, E González-Roca… - JBMR …, 2018 - pubmed.ncbi.nlm.nih.gov
Atypical femoral fractures (AFFs) are uncommon and often related to prolonged
bisphosphonate (BP) treatment. Isolated cases have been linked to mutations of tissue …
bisphosphonate (BP) treatment. Isolated cases have been linked to mutations of tissue …
Incidence of Mutations in the ALPL, GGPS1, and CYP1A1 Genes in Patients With Atypical Femoral Fractures.
P Peris, E Roca, SC García, MDM Cobo, A Monegal… - JBMR Plus, 2018 - go.gale.com
Atypical femoral fractures (AFFs) are uncommon and often related to prolonged
bisphosphonate (BP) treatment. Isolated cases have been linked to mutations of tissue …
bisphosphonate (BP) treatment. Isolated cases have been linked to mutations of tissue …
Incidence of Mutations in the ALPL, GGPS1, and CYP1A1 Genes in Patients With Atypical Femoral Fractures.
P Peris, E González-Roca, SC Rodríguez-García… - JBMR Plus, 2018 - europepmc.org
Atypical femoral fractures (AFFs) are uncommon and often related to prolonged
bisphosphonate (BP) treatment. Isolated cases have been linked to mutations of tissue …
bisphosphonate (BP) treatment. Isolated cases have been linked to mutations of tissue …